| Author | Year | No. of patients | Outcomes | Risk of basis | HSS+ furosemide | Furosemide |
| Issa et al. [21] | 2013 | 20 | 12 | Urine output, length of stay, readmission rate, hospitalization cost, mortality, readmission time | Uncertain | Licata et al. [19] | 2003 | 53 | 54 | Urine output, serum creatinine, readmission rate, mortality, body weight | Uncertain | Okuhara et al. [22] | 2014 | 22 | 22 | Urine output, brain natriuretic peptide, natriuretic capacity, length of hospital stay, readmission rate, mortality | Low | Parrinello et al. [23] | 2012 | 66 | 67 | Length of hospital stay, readmission, and mortality | Uncertain | Parrinello et al. [24] | 2011 | 122 | 126 | Urine volume, serum creatinine, readmission rate, length of hospital stay, natriuretic capacity, body weight, mortality | Uncertain | Paterna et al. [25] | 2005 | 30 | 30 | Brain natriuretic peptide, body weight, urine volume, serum creatinine | Uncertain | Paterna et al. [26] | 2011 | 48 | 46 | Serum creatinine, body weight, length of stay, readmission rate | Uncertain | Paterna et al. [27] | 2000 | 881 | 890 | Urine volume, serum creatinine, body weight, readmission rate, mortality | Uncertain | Wan et al. [28] | 2017 | 132 | 132 | Urine volume, serum creatinine, body weight, brain natriuretic peptide | Uncertain | Yayla et al. [20] | 2015 | 14 | 14 | Urine volume, serum creatinine, body weight | Low |
|
|